Katy Shaw-Saliba is the VP of Scientific Development at Infinity Bio, Inc. , a seasoned executive with deep expertise in clinical research, laboratory science, and R&D pipelines. With a PhD from Johns Hopkins, she specializes in translating complex data into high-impact scientific communications and strategy, with a focus on antibody response.
She is passionate about human health and fostering global scientific relationships, demonstrated by her collaborative clinical research in West and Central Africa. Katy values her connections with international colleagues, such as her team in Mali, viewing them as lifelong partners in advancing science and health.
Unique fact: While at the NIAID, she directed multi-million dollar global clinical research studies, including a $3. 3M measles vaccine initiative and trials for Ebola virus countermeasures.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.